JP MORGAN/PUT/ABBOTT LABORATORIES/100/0.1/15.11.24 Stock

Warrant

DE000JK4CP91

Market Closed - Börse Stuttgart 04:58:23 2024-07-05 EDT
0.39 EUR +2.63% Intraday chart for JP MORGAN/PUT/ABBOTT LABORATORIES/100/0.1/15.11.24
Current month+25.81%
1 month+14.71%
Date Price Change
24-07-05 0.39 +2.63%
24-07-04 0.38 +8.57%
24-07-03 0.35 -2.78%
24-07-02 0.36 +12.50%
24-07-01 0.32 +3.23%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 04:58 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK4CP9
ISINDE000JK4CP91
Date issued 2024-03-19
Strike 100 $
Maturity 2024-11-15 (131 Days)
Parity 10 : 1
Emission price 0.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.24
Spread 0.01
Spread %2.94%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
124.9 USD
Spread / Average Target
+20.09%
Consensus